Literature DB >> 14629990

Relapse in outpatient treatment for marijuana dependence.

Brent A Moore1, Alan J Budney.   

Abstract

The current study provides an initial examination of lapse and relapse to marijuana use among 82 individuals who achieved at least 2 weeks of abstinence during outpatient treatment for marijuana dependence. Seventy-one percent used marijuana at least once (i.e., lapsed) within 6 months of initial abstinence, averaging 73 days (SD = 50) till lapsing. Similarly, 71% of those who lapsed, relapsed to heavier use defined as at least 4 days of marijuana use in any 7-day period. Early lapses were more strongly associated with consequent relapse. Previous studies have noted that marijuana-dependent outpatients experience difficulty initiating abstinence from marijuana much as do those dependent on other substances. The present data suggest that these similarities extend to difficulty maintaining abstinence.

Entities:  

Mesh:

Year:  2003        PMID: 14629990     DOI: 10.1016/s0740-5472(03)00083-7

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  32 in total

Review 1.  The marijuana withdrawal syndrome: diagnosis and treatment.

Authors:  Margaret Haney
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

2.  Abstinence rates following behavioral treatments for marijuana dependence.

Authors:  Ronald M Kadden; Mark D Litt; Elise Kabela-Cormier; Nancy M Petry
Journal:  Addict Behav       Date:  2006-09-22       Impact factor: 3.913

3.  Modeling the complexity of post-treatment drinking: it's a rocky road to relapse.

Authors:  Katie Witkiewitz; G Alan Marlatt
Journal:  Clin Psychol Rev       Date:  2007-01-18

4.  Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2011-01-11       Impact factor: 4.492

5.  Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Authors:  Margaret Haney; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Stephanie Collins Reed; Ziva D Cooper; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-03       Impact factor: 4.530

Review 6.  Marijuana dependence: not just smoke and mirrors.

Authors:  Divya Ramesh; Joel E Schlosburg; Jason M Wiebelhaus; Aron H Lichtman
Journal:  ILAR J       Date:  2011

7.  Continuous Abstinence During Early Alcohol Treatment is Significantly Associated with Positive Treatment Outcomes, Independent of Duration of Abstinence.

Authors:  Kelly E Dunn; Joseph A Harrison; Jeannie-Marie Leoutsakos; Dingfen Han; Eric C Strain
Journal:  Alcohol Alcohol       Date:  2016-08-27       Impact factor: 2.826

8.  Integrated cognitive behavioral therapy for cannabis use and anxiety disorders: rationale and development.

Authors:  Julia D Buckner; Michael J Zvolensky; Norman B Schmidt; Kathleen M Carroll; Chris Schatschneider; Kathleen Crapanzano
Journal:  Addict Behav       Date:  2013-10-29       Impact factor: 3.913

Review 9.  Marijuana neurobiology and treatment.

Authors:  Ahmed Elkashef; Frank Vocci; Marilyn Huestis; Margaret Haney; Alan Budney; Amanda Gruber; Nady el-Guebaly
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

10.  Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.

Authors:  Margaret Haney; Carl L Hart; Suzanne K Vosburg; Sandra D Comer; Stephanie Collins Reed; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2007-12-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.